日本の体外診断 (IVD) 市場：診断項目、企業、医療費償還、ポーターモデル、成長促進要因、課題、機会
Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges
|出版日||ページ情報||英文 144 Pages
|日本の体外診断 (IVD) 市場：診断項目、企業、医療費償還、ポーターモデル、成長促進要因、課題、機会 Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges|
|出版日: 2020年05月01日||ページ情報: 英文 144 Pages||
当レポートでは、日本における体外診断 (IVD) の市場について分析し、市場の基本構造や背景事情・政策環境、市場全体および部門別の動向見通し、市場の促進・抑制要因と求心力、主要企業のプロファイル・業績・戦略などについて調査しております。
As most of the industry growth rate in Japan is hit due to COVID-19, but on the contrary, Japan In-Vitro Diagnostics Market is expected to put an exceptional higher growth rate in 2020 compared to its past years (read the report for Coronavirus impact on IVD industry of Japan). According to our research report, Japan In-vitro Diagnostic Market is projected to reach US$ 4.43 Billion by 2026.
In-vitro Diagnostics falls under the medical devices segment, which is used by disposable & consumable, and it is also used in many different, different types of medical tones to find multiple bio-samples. In recent years, several developments have happened in the field of In-vitro diagnostics like conventional diagnostics to new generation gene diagnostics. This has become possible with the advent of new technologies, such as genetic testing, chain reaction (PCR), next-generation sequencing (NGS), and molecular diagnostics.
In Japan, a quarter of its population age 65 years & above and also has the highest proportion of the aging population across the globe. The main problem faced by the Japanese government in recent years is the rise in the number of an aging population, as the cases of aging diseases are multiplying. Accordingly, the Japanese government has given priority to deal with the aging population, and the government is expected to devote an expanded health budget to aging by 2025. This will boost the future of the Japanese In-Vitro Diagnostics Industry by rising prevalence and increased public expenditure.
Apart from that enhanced diagnostic technology, people's awareness and the subsequent growth in the prevalence of chronic and infectious diseases, a rise in the number of private hospitals, and independent testing laboratories are also some of the other factors that contribute to its market growth. Japan's clinical laboratory markets represent one of the largest and fastest-growing markets among the top ten IVD nation markets in the Asia Pacific regions.
Renub Research report titled "Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Tumor Marker, Urine & Feces, Clinical Chemistry, Hematology, Self Monitoring of Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Abbott Laboratories, Danaher Corporation, Biomerieux, Roche Diagnostics, and Becton Dickinson), Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges" provides a complete analysis of Japan In Vitro Diagnostics (IVD) Market.
In this report, we have provided a complete analysis of 11 segments of the Japan In-vitro Diagnostic market. These segments are as follows Clinical Chemistry, Urine & Feces, Hematology, Tumor Marker, Self Monitoring Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing, and Others. In these In vitro diagnostics segments, we have done a comprehensive analysis of each segment due to COVID-19 along with separate growth factors for each segment.
Our report describes the scope and breadth of the reimbursement policies along with the full context. It also provides specific guidance and structure about how it operates and how Japanese authorities implement reimbursement policies. It describes how medical devices are categorized in Japan and which class In vitro diagnostic suits. It includes all medical manufacturers that have been in Japan for the past five years applying for reimbursement approval.
This research report provides a compressive study of all the 5 Porter's forces and their significant effect on Japan IVD industry.